This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.
The company is making its entry into the Hyderabad market through its unique asset-light business model
The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.
The European Commission will review the CHMP recommendation and is expected to make a final decision soon.
The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal
Dr. Mandaviya agreed to host the Stop TB Partnership’s 36th Board meeting on March 25-26, 2023 in Varanasi
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
Subscribe To Our Newsletter & Stay Updated